Cefdinir
- Product NDC
- 0093-3160
- 11-digit product format
- 000933160
- Labeler code
- 0093
- Product ID
- 0093-3160_588d0980-34a4-45b5-a1ca-a16ed3faa2be
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefdinir
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA065368
- Marketing category
- ANDA
- Marketing start
- 2007-05-09
- Substance
- CEFDINIR
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cefdinir
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEFDINIR | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | CI0FAO63WC |
| Rxcui | 200346 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0093-3160-06 | Cefdinir | 60 in 1 BOTTLE | CAPSULE | 60 | | 16 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0093-3160 | CEFDINIR CAPSULE [TEVA PHARMACEUTICALS USA, INC.] | 16 | Current NDC, Legacy NDC, 1 package rows | 20240209_de3441e3-7fd2-4d29-a8b7-0f9b66e35c9c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-3160-06 | 00093316006 | 60 CAPSULE in 1 BOTTLE (0093-3160-06) | 60 capsule | 2007-05-09 | 0000-00-00 | No | No | Current |